Publication of the final decisions for substances referred to the March 2023 meetings of the Advisory Committee on Medicines Scheduling (ACMS #41), Advisory Committee on Chemicals Scheduling (ACCS #36) and Joint Advisory Committee on Medicines and Chemicals Scheduling (Joint ACMS-ACCS #33), have been delayed.
The final decisions which were expected to be published in August 2023, are now to be published in September 2023.
